Stage IIIA Non-Small Cell Lung Cancer
Showing 1 - 25 of 71
Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)
Not yet recruiting
- Stage IIIB(N2) Non-small Cell Lung Cancer
- +3 more
- Pembrolizumab 200 mg IV infusion
-
Beijing, Beijing, ChinaPeking University
May 30, 2023
Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)
Terminated
- Stage IIIA Non-Small Cell Lung Cancer
- Cisplatin
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022
Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (drug, procedure, radiation)
Recruiting
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Durvalumab
- +2 more
-
San Diego, California
- +14 more
Dec 5, 2022
Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,
Active, not recruiting
- Non-Squamous Non-Small Cell Lung Carcinoma
- +7 more
- Nivolumab
- +3 more
-
Abington, Pennsylvania
- +1 more
Sep 14, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body
Completed
- Recurrent Non-small Cell Lung Cancer
- +3 more
- therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
- quality-of-life assessment
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,
Recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +7 more
- Auranofin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jun 27, 2022
Pathological Response After Neoadjuvant Treatment on NSCLC
Recruiting
- Stage IIIA Non-small Cell Lung Cancer
-
Badalona, Barcelona, Spain
- +16 more
Jun 1, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)
Recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Dexamethasone
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial
Completed
- Metastatic Malignant Neoplasm in the Brain
- +6 more
- Carboplatin
- +5 more
-
Bronx, New York
- +1 more
Jan 20, 2022
Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive
Completed
- Febrile Neutropenia
- +27 more
- Preventive Intervention
- +2 more
-
Jonesboro, Arkansas
- +159 more
Dec 22, 2021
Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)
Active, not recruiting
- Adenocarcinoma of the Lung
- +8 more
- hypofractionated radiation therapy
- +5 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Dec 2, 2021
Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- +5 more
- TG4010
- Nivolumab
-
Duarte, California
- +3 more
Oct 11, 2021
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Afatinib Dimaleate
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Sep 29, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in Los Angeles (Laboratory Biomarker Analysis, Pembrolizumab)
Completed
- Stage IIIA Non-Small Cell Lung Cancer
- +2 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 24, 2021
Stage IIIA NSCLC Trial in Philadelphia (radiation, drug, procedure)
Completed
- Stage IIIA Non-small Cell Lung Cancer
- proton beam radiation therapy
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Apr 23, 2021
Recurrent NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Columbus (radiation, drug, other)
Unknown status
- Recurrent Non-small Cell Lung Cancer
- +4 more
- hypofractionated radiation therapy
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 24, 2020
Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in United States (dietary
Completed
- Adenocarcinoma of the Lung
- +7 more
- soy isoflavones
- +4 more
-
Bay City, Michigan
- +4 more
Nov 19, 2020
Recurrent Non-Small Cell Lung Carcinoma, Stage III NSCLC, Stage IIIA NSCLC Trial in Chicago, Lake Forest (other, drug,
Active, not recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Chicago, Illinois
- +1 more
Sep 20, 2020
Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Bronx, New York (drug, procedure, other)
Terminated
- Stage IIIA Non-Small Cell Lung Cancer
- Stage IIIB Non-Small Cell Lung Cancer
- Erlotinib Hydrochloride
- +2 more
-
Bronx, New York
- +2 more
Jun 24, 2020
Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IIIA NSCLC Trial (drug, other, genetic)
Withdrawn
- Recurrent Non-small Cell Lung Cancer
- +5 more
- sirolimus
- +4 more
- (no location specified)
Mar 30, 2020